Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine
- 1 November 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 299 (5), G1068-G1077
- https://doi.org/10.1152/ajpgi.00249.2010
Abstract
Nonalcoholic fatty liver (NAFL) is a common liver disease, associated with insulin resistance. Betaine has been tested as a treatment for NAFL in animal models and in small clinical trials, with mixed results. The present study aims to determine whether betaine treatment would prevent or treat NAFL in mice and to understand how betaine reverses hepatic insulin resistance. Male mice were fed a moderate high-fat diet (mHF) containing 20% of calories from fat for 7 (mHF) or 8 (mHF8) mo without betaine, with betaine (mHFB), or with betaine for the last 6 wk (mHF8B). Control mice were fed standard chow containing 9% of calories from fat for 7 mo (SF) or 8 mo (SF8). HepG2 cells were made insulin resistant and then studied with or without betaine. mHF mice had higher body weight, fasting glucose, insulin, and triglycerides and greater hepatic fat than SF mice. Betaine reduced fasting glucose, insulin, triglycerides, and hepatic fat. In the mHF8B group, betaine treatment significantly improved insulin resistance and hepatic steatosis. Hepatic betaine content significantly decreased in mHF and increased significantly in mHFB. Betaine treatment reversed the inhibition of hepatic insulin signaling in mHF and in insulin-resistant HepG2 cells, including normalization of insulin receptor substrate 1 (IRS1) phosphorylation and of downstream signaling pathways for gluconeogenesis and glycogen synthesis. Betaine treatment prevents and treats fatty liver in a moderate high-dietary-fat model of NAFL in mice. Betaine also reverses hepatic insulin resistance in part by increasing the activation of IRS1, with resultant improvement in downstream signaling pathways.Keywords
This publication has 55 references indexed in Scilit:
- Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Impaired PRMT1 activity in the liver and pancreas of type 2 diabetic Goto–Kakizaki ratsLife Sciences, 2009
- Alleviation of dimethylnitrosamine-induced liver injury and fibrosis by betaine supplementation in ratsChemico-Biological Interactions, 2009
- Osmosensing and osmosignaling in the liverWiener Medizinische Wochenschrift, 2008
- Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathwayJournal of Hepatology, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Swelling of hepatocytes injured by oxidative stress suggests pathological changes related to macromolecular crowdingMedical Hypotheses, 2005
- Effects of betaine supplementation on hepatic metabolism of sulfur-containing amino acids in miceJournal of Hepatology, 2005
- Hyperosmotic Stress Inhibits Insulin Receptor Substrate-1 Function by Distinct Mechanisms in 3T3-L1 AdipocytesPublished by Elsevier BV ,2003